We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-2.64%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$34.8B
AUM Growth
+$3.48B
Cap. Flow
+$9.84B
Cap. Flow %
28.29%
Top 10 Hldgs %
40.9%
Holding
1,487
New
119
Increased
700
Reduced
287
Closed
311

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.2B
2
NVDA icon
NVIDIA
NVDA
+$662M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$581M
4
MU icon
Micron Technology
MU
+$479M
5
AVGO icon
Broadcom
AVGO
+$470M

Sector Composition

Rank Sector Weight
1 Technology 34.26%
2 Real Estate 23.49%
3 Communication Services 13.02%
4 Consumer Discretionary 6.46%
5 Financials 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALT icon
1176
Altimmune
ALT
$539M
-235
Closed -$1K
ALVO icon
1177
Alvotech
ALVO
$1.03B
-1,030
Closed -$5K
AMBA icon
1178
Ambarella
AMBA
$2.99B
-848
Closed -$60K
AMLX icon
1179
Amylyx Pharmaceuticals
AMLX
$2.05B
-266
Closed -$3K
AMPH icon
1180
Amphastar Pharmaceuticals
AMPH
$825M
-135
Closed -$4K
AMRX icon
1181
Amneal Pharmaceuticals
AMRX
$5.72B
-933
Closed -$12K
ANAB icon
1182
AnaptysBio
ANAB
$1.6B
-75
Closed -$4K
ANIP icon
1183
ANI Pharmaceuticals
ANIP
$1.77B
-70
Closed -$6K
ANNX icon
1184
Annexon
ANNX
$855M
-352
Closed -$2K
APGE icon
1185
Apogee Therapeutics
APGE
$10.2B
-166
Closed -$13K
APLS
1186
DELISTED
Apellis Pharmaceuticals
APLS
-369
Closed -$9K
AQST icon
1187
Aquestive Therapeutics
AQST
$462M
-500
Closed -$3K
ARCT icon
1188
Arcturus Therapeutics
ARCT
$157M
-90
Closed -$1K
ARDX icon
1189
Ardelyx
ARDX
$1.24B
-754
Closed -$4K
ARQT icon
1190
Arcutis Biotherapeutics
ARQT
$3.42B
-358
Closed -$10K
ARVN icon
1191
Arvinas
ARVN
$518M
-252
Closed -$3K
ARWR icon
1192
Arrowhead Research
ARWR
$12.1B
-1,377
Closed -$91K
ASAN icon
1193
Asana
ASAN
$1.58B
-4,595
Closed -$63K
AUPH icon
1194
Aurinia Pharmaceuticals
AUPH
$1.97B
-413
Closed -$7K
AURA icon
1195
Aura Biosciences
AURA
$729M
-165
Closed -$1K
AUTL
1196
Autolus Therapeutics
AUTL
$386M
-575
Closed -$1K
AVAV icon
1197
AeroVironment
AVAV
$7.57B
-97,890
Closed -$23.7M
AVIR icon
1198
Atea Pharmaceuticals
AVIR
$379M
-242
Closed -$1K
AVXL icon
1199
Anavex Life Sciences
AVXL
$222M
-314
Closed -$1K
AXP icon
1200
PUT
American Express
AXP
$223B
-220,000
Closed -$81.4M

Similar funds

Daiwa Securities Group's Q1 2026 Portfolio in Review

As of Q1 2026, Daiwa Securities Group held 1,487 positions worth $34.8B, up 11% from $31.3B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Daiwa Securities Group deployed $9.84B of net new capital in Q1 2026, opening 119 new positions and adding to 700 existing holdings. Its largest new stake was York Space Systems: 622,792 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Real Estate and Communication Services.

On the sell side, the largest reduction was CrowdStrike, an estimated $612M trimmed.

  • Daiwa Securities Group's largest Q1 2026 buy was York Space Systems: 622,792 shares worth $13.8M.
  • Daiwa Securities Group added most to Microsoft in Q1 2026, an estimated $1.2B increase.
  • Daiwa Securities Group's biggest Q1 2026 reduction was CrowdStrike, cutting an estimated $612M.
  • Daiwa Securities Group fully exited iShares Bitcoin Trust in Q1 2026, selling an estimated $94.1M.
  • Daiwa Securities Group's ten largest holdings make up 41% of its $34.8B portfolio in Q1 2026.
  • Daiwa Securities Group opened 119 new positions and closed 311 in Q1 2026.
  • Daiwa Securities Group's portfolio value rose 11% quarter-over-quarter to $34.8B.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.